Mo Chen, Yuan Zhang, Xiao-Ting Que, Ya Ding, Lin Yang, Ai-Dong Wen, Tai-Jun Hang. Pharmacokinetic study of inosiplex tablets in healthy Chinese volunteers by hyphenated HPLC and tandem MS techniques[J]. Journal of Pharmaceutical Analysis, 2013, (6): 387-393.
Citation:
Mo Chen, Yuan Zhang, Xiao-Ting Que, Ya Ding, Lin Yang, Ai-Dong Wen, Tai-Jun Hang. Pharmacokinetic study of inosiplex tablets in healthy Chinese volunteers by hyphenated HPLC and tandem MS techniques[J]. Journal of Pharmaceutical Analysis, 2013, (6): 387-393.
Mo Chen, Yuan Zhang, Xiao-Ting Que, Ya Ding, Lin Yang, Ai-Dong Wen, Tai-Jun Hang. Pharmacokinetic study of inosiplex tablets in healthy Chinese volunteers by hyphenated HPLC and tandem MS techniques[J]. Journal of Pharmaceutical Analysis, 2013, (6): 387-393.
Citation:
Mo Chen, Yuan Zhang, Xiao-Ting Que, Ya Ding, Lin Yang, Ai-Dong Wen, Tai-Jun Hang. Pharmacokinetic study of inosiplex tablets in healthy Chinese volunteers by hyphenated HPLC and tandem MS techniques[J]. Journal of Pharmaceutical Analysis, 2013, (6): 387-393.
Inosiplex is a compound formulation composed of inosine and p-acetaminobenzoic acid (PABA) salt of N,N-dimethylamino-2-propanol (DIP). This study was to investigate the clinical plasma pharmacokinetic properties of DIP and PABA after single and multiple oral doses of inosiplex tablets in healthy Chinese volunteers. The established LC/MS/MS method for plasma DIP determination had a linear range of 0.02-10 mg/mL, and the HPLC method for plasma PABA determination had a linear range of 0.05-40 mg/mL. Linear pharmacokinetic characteristics were found with single oral doses of 0.5, 1.0 and 2.0 g. No obvious accumulation effects were observed for DIP and PABA.